Elizabeth Hirsch

Elizabeth Hirsch is an Associate Professor in the Department of Experimental and Clinical Pharmacology (ECP) at the College of Pharmacy, University of Minnesota. She focuses on multidrug-resistant (MDR) Gram-negative infections, bridging laboratory research with clinical applications to optimize antimicrobial use.

Education & Training:

• PGY1 Residency, St. Luke's Episcopal Hospital (Houston, TX)
• Infectious Diseases Pharmacotherapy Fellowship, University of Houston College of Pharmacy and St. Luke's Episcopal Hospital

Her research expertise includes pharmacokinetics/pharmacodynamics of antimicrobials, antimicrobial susceptibility testing, and rapid diagnostics. She contributes to clinical and pre-clinical antimicrobial development and evaluation.

The 15 most recent articles highlight her work on fosfomycin resistance mechanisms, antimicrobial stewardship (OPAT, value-based care), and disparities in healthcare data. Key trends involve improving susceptibility testing accuracy and addressing systemic inequities in treatment access.

Scientific Awards:

• Fellow, American College of Clinical Pharmacy (FCCP)
• Fellow, Infectious Diseases Society of America (FIDSA)
• Fellow, International Society for Infectious Diseases (FIDP)

She is actively involved in professional associations such as the American Society for Microbiology, Clinical and Laboratory Standards Institute (CLSI), and Society of Infectious Diseases Pharmacists. Her teaching areas include infectious diseases pharmacotherapy and course directorship for PHAR 6768.